Chi2gel

Hybrid Hydrogels for Orthopedics and Rheumatology

Health Tech & Life Sciences
Non Active, May 2019 ceased to operate
Seed Ofakim Founded 2008
LinkedIn
Total raised
$658K
Last: Undisclosed 2010-09
Stage
Seed
Founded
2008
Headcount
1-10
HQ
Ofakim
Sector
Health Tech & Life Sciences

About

Chi2Gel is a development-stage company that intends to develop a hydrogel-based device to revitalize degenerated spinal discs. The companys proprietary hybrid hydrogel is currently in advanced preclinical development in the fields of orthopedics and rheumatology. Chi2Gels current development focus is on patients with painful knee osteoarthritis, for whom Chi2Knee will be indicated for intra-articular injection as a viscosupplement. Chi2Gels hydrogel will later be developed for lower back pain related to degenerative disc disease, in which Chi2Disc will be used in conjunction with a proprietary disc-restorative device.

Funding history · 1 round · $658K total

2010-09
Undisclosed $658K

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesPolymers
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyHealthcareProviders
Business model
B2BB2G

Highlights

1 Patents

Tags

osteoarthritisorthopedicsdegenerative-diseasesmedical-devicespolymers